Shared on 04 Aug 25

Fair value Increased 6.90%

Analysts raised their price target for Performant Healthcare to $7.75, citing its leading role in healthcare payment integrity, favorable momentum from its new New York Medicaid contract, and confidence in its scalable, diversified business model. Analyst Commentary Recognition of Performant as a leading technology-enabled healthcare payment integrity vendor.

Read more

0 votesShare

Shared on 01 May 25

Fair value Decreased 0.55%

Read more

0 votesShare

Shared on 24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 09 Apr 25

Fair value Increased 0.55%

AnalystConsensusTarget has increased revenue growth from 7.9% to 9.7%, decreased profit margin from 4.6% to 3.5%, increased future PE multiple from 91.5x to 120.6x and increased shares outstanding growth rate from 0.0% to 0.0%.

Read more

0 votesShare